Significant Ownership of Vifor (International) Ltd
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Vifor (International) Ltd focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Alexandros Sigalas - Alexandros Sigalas, Head of Finance, CSL Vifor
- Manager location
- St. Gallen, Switzerland
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Vifor (International) Ltd with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Vifor (International) Ltd
Significant Ownership of Vifor (International) Ltd
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CARA | Cara Therapeutics, Inc. | Common Stock, par value $0.001 per share | 14% | $2,458,686 | 7,396,770 | Vifor (International) Ltd. | 17 Dec 2024 | ||
| TVRD | Tvardi Therapeutics, Inc. (formerly, Cara Therapeutics, Inc.) | Common Stock, par value $0.001 per share | 2.2% | $4,725,695 | 205,465 | Vifor (International) Ltd. | 15 Apr 2025 |
Schedules 13D/G Reported by Vifor (International) Ltd:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.